Richard Atkin to Join MedTech Nordic Investing & Partnering 2013
HELSINKI, April 16, 2013 /PRNewswire/ --
Richard Atkin, President of Sunquest Information Systems, will join the 3rd MedTech Nordic Investing & Partnering 2013 event as a keynote speaker. The MedTech Nordic event is the foremost medical technology event in the Nordic countries. This year it will be held in Helsinki on September 3rd. The event brings together leading experts and investors in the field.
Richard Atkin's career has spanned numerous industry leadership roles, including President and CEO of Datex-Ohmeda Inc., now part of GE Healthcare, CEO of Spacelabs Medical and former Commissioner for CCHIT. Richard is also President of American Interfaith Camps, Inc., a charitable organization that promotes interfaith dialogue and understanding and a board member of Misys Banking Systems, a London-based Banking Software company with revenues of nearly $1BN.
Sunquest Information Systems is the global market leader in laboratory software. Sunquest provides solutions that enable the full automation of hospital laboratories and also solutions that extend across the continuum of care to all areas of healthcare where lab tests are ordered, samples are collected, or results are needed to make effective clinical decisions.
Sunquest was acquired by Roper Industries in July 2012. After the acquisition Brian Jellison, Roper's Chairman, President and CEO, applauded the Sunquest leadership team as follows: "Sunquest is led by an outstanding and proven leadership team that impressed us with their culture of execution and the results they have created. We look forward to working with the Sunquest team to enhance the value of the business for the benefit of customers, employees and shareholders. The business will continue as Sunquest, marketing products and services under current brand names."
"We are much honored to have Richard Atkin as our guest in Helsinki. Richard's experience in growing the shareholder value of businesses as well as having been an active player in several acquisitions and exits will be very valuable for the Nordic medtech society," said Jan Ekström, project manager of MedTech Nordic Investing & Partnering 2013.
In addition to Mr. Atkin's keynote speech, the MedTech Nordic Investing & Partnering event will include an interesting panel debate between industry representatives Mette-Marie Harild, VP of North-East Europe of Medtronic, Peter Crosby, CEO of Mainstay and Seppo Kopsala, CEO of Optomed, and venture capital investor representatives Katie Ellias, senior associate at Sofinnova, and Killu Sanborn, Director of business development at Oxford Finance.
"This will not be all. More interesting additions to the program are being planned and we are confident that the event will once again meet the expectations of all participants," Ekström concludes.
For further information on the event and contacts, visit: http://www.medtechnordicinvest.com.
Share this article